IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
INR 61.65
(3.88%)
INR 61.65
(3.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.71 Billion INR | -29.57% |
| 2022 | 6.7 Billion INR | 17.2% |
| 2021 | 5.71 Billion INR | -30.45% |
| 2020 | 8.21 Billion INR | 5.54% |
| 2019 | 7.78 Billion INR | 32.44% |
| 2018 | 5.88 Billion INR | 134.65% |
| 2017 | 2.5 Billion INR | 14.02% |
| 2016 | 2.19 Billion INR | 31.77% |
| 2015 | 1.66 Billion INR | 58.12% |
| 2014 | 1.05 Billion INR | -45.5% |
| 2013 | 1.93 Billion INR | 6.63% |
| 2012 | 1.81 Billion INR | 6.33% |
| 2011 | 1.7 Billion INR | 60.98% |
| 2010 | 1.06 Billion INR | 56.52% |
| 2009 | 677.57 Million INR | 25.24% |
| 2008 | 541.03 Million INR | -10.25% |
| 2007 | 602.82 Million INR | 94.47% |
| 2006 | 309.99 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 961.4 Million INR | -16.63% |
| 2023 FY | 4.71 Billion INR | -29.57% |
| 2023 Q1 | 1.98 Billion INR | -5.4% |
| 2023 Q2 | 1.91 Billion INR | -3.25% |
| 2023 Q3 | 1.64 Billion INR | -14.26% |
| 2023 Q4 | 1.15 Billion INR | -29.87% |
| 2022 FY | 6.7 Billion INR | 17.2% |
| 2022 Q2 | 1.38 Billion INR | -18.66% |
| 2022 Q3 | 1.51 Billion INR | 9.17% |
| 2022 Q1 | 1.7 Billion INR | 67.17% |
| 2022 Q4 | 2.09 Billion INR | 38.43% |
| 2021 Q1 | 1.83 Billion INR | 30.54% |
| 2021 Q2 | 1.32 Billion INR | -27.94% |
| 2021 FY | 5.71 Billion INR | -30.45% |
| 2021 Q3 | 1.54 Billion INR | 16.6% |
| 2021 Q4 | 1.01 Billion INR | -33.84% |
| 2020 Q3 | 2.26 Billion INR | -6.7% |
| 2020 FY | 8.21 Billion INR | 5.54% |
| 2020 Q1 | 2.11 Billion INR | 42.77% |
| 2020 Q4 | 1.4 Billion INR | -38.0% |
| 2020 Q2 | 2.42 Billion INR | 14.66% |
| 2019 Q2 | 1.96 Billion INR | -7.26% |
| 2019 Q3 | 2.21 Billion INR | 12.92% |
| 2019 Q4 | 1.48 Billion INR | -33.14% |
| 2019 FY | 7.78 Billion INR | 32.44% |
| 2019 Q1 | 2.11 Billion INR | 29.02% |
| 2018 Q4 | 1.64 Billion INR | -18.14% |
| 2018 Q2 | 1.34 Billion INR | 50.47% |
| 2018 FY | 5.88 Billion INR | 134.65% |
| 2018 Q1 | 890.8 Million INR | 15.48% |
| 2018 Q3 | 2 Billion INR | 49.72% |
| 2017 Q1 | 639.8 Million INR | 7.86% |
| 2017 FY | 2.5 Billion INR | 14.02% |
| 2017 Q4 | 771.4 Million INR | -0.44% |
| 2017 Q3 | 774.8 Million INR | 13.59% |
| 2017 Q2 | 682.1 Million INR | 6.61% |
| 2016 FY | 2.19 Billion INR | 31.77% |
| 2016 Q2 | 575.8 Million INR | 4.23% |
| 2016 Q3 | 591.2 Million INR | 2.67% |
| 2016 Q1 | 552.45 Million INR | 6.74% |
| 2016 Q4 | 593.2 Million INR | 0.34% |
| 2015 Q2 | 374.75 Million INR | 17.2% |
| 2015 Q4 | 517.54 Million INR | 13.49% |
| 2015 Q1 | 319.76 Million INR | 119.45% |
| 2015 Q3 | 456.03 Million INR | 21.69% |
| 2015 FY | 1.66 Billion INR | 58.12% |
| 2014 Q4 | 145.71 Million INR | 0.15% |
| 2014 Q3 | 145.49 Million INR | -51.36% |
| 2014 Q1 | 464.61 Million INR | 3.99% |
| 2014 FY | 1.05 Billion INR | -45.5% |
| 2014 Q2 | 299.15 Million INR | -35.61% |
| 2013 Q4 | 446.79 Million INR | -9.61% |
| 2013 Q2 | 528.83 Million INR | 15.06% |
| 2013 Q1 | 459.62 Million INR | 0.08% |
| 2013 Q3 | 494.29 Million INR | -6.53% |
| 2013 FY | 1.93 Billion INR | 6.63% |
| 2012 Q4 | 459.26 Million INR | 1.47% |
| 2012 Q3 | 452.61 Million INR | 1.41% |
| 2012 Q2 | 446.33 Million INR | -2.36% |
| 2012 Q1 | 457.13 Million INR | 0.0% |
| 2012 FY | 1.81 Billion INR | 6.33% |
| 2011 FY | 1.7 Billion INR | 60.98% |
| 2010 FY | 1.06 Billion INR | 56.52% |
| 2009 FY | 677.57 Million INR | 25.24% |
| 2008 FY | 541.03 Million INR | -10.25% |
| 2007 FY | 602.82 Million INR | 94.47% |
| 2006 FY | 309.99 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 82.379% |
| Hester Biosciences Limited | 1.27 Billion INR | -270.518% |
| Aarti Drugs Limited | 8.31 Billion INR | 43.254% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | 19.074% |
| Albert David Limited | 1.4 Billion INR | -235.143% |
| Alembic Limited | 1 Billion INR | -371.86% |
| Alkem Laboratories Limited | 52.29 Billion INR | 90.976% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -943.695% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -220.633% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -37517.377% |
| Brooks Laboratories Limited | 65.62 Million INR | -7091.557% |
| Eris Lifesciences Limited | 10.42 Billion INR | 54.741% |
| FDC Limited | 6.58 Billion INR | 28.349% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | 62.044% |
| Gufic Biosciences Limited | 4.07 Billion INR | -15.842% |
| Hikal Limited | 5.95 Billion INR | 20.794% |
| Ind-Swift Limited | 2.17 Billion INR | -117.217% |
| Innova Captab Limited | 3.46 Billion INR | -36.215% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -623.134% |
| Jubilant Pharmova Limited | 19.64 Billion INR | 75.976% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -150.103% |
| Lupin Limited | 125.09 Billion INR | 96.228% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -582.747% |
| Medico Remedies Limited | 262.14 Million INR | -1700.194% |
| Morepen Laboratories Limited | 6.16 Billion INR | 23.407% |
| Nectar Lifesciences Limited | 4.82 Billion INR | 2.16% |
| Orchid Pharma Limited | 2.32 Billion INR | -103.383% |
| Procter & Gamble Health Limited | 5.78 Billion INR | 18.374% |
| RPG Life Sciences Limited | 2.48 Billion INR | -90.056% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -660.56% |
| Sigachi Industries Limited | 2 Billion INR | -135.686% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 384.987% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -14.45% |
| Themis Medicare Limited | 2.42 Billion INR | -95.004% |
| Unichem Laboratories Limited | 4.86 Billion INR | 2.998% |
| Vaishali Pharma Limited | 90.32 Million INR | -5124.694% |
| Wanbury Limited | 1.73 Billion INR | -172.679% |
| Windlas Biotech Limited | 1.33 Billion INR | -252.487% |
| ZIM Laboratories Limited | 1.26 Billion INR | -272.224% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -14.175% |
| Ipca Laboratories Limited | 48.58 Billion INR | 90.287% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 98.174% |
| Venus Remedies Limited | 2.18 Billion INR | -116.216% |
| Sakar Healthcare Limited | 699.58 Million INR | -574.557% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 95.692% |
| Divi's Laboratories Limited | 32.44 Billion INR | 85.453% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | 24.163% |
| Mankind Pharma Limited | 42.19 Billion INR | 88.816% |
| Sequent Scientific Limited | 2.97 Billion INR | -58.427% |
| Laurus Labs Limited | 15.44 Billion INR | 69.453% |
| Neuland Laboratories Limited | 8.24 Billion INR | 42.784% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | 69.073% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 93.194% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 96.231% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -125.359% |
| Wockhardt Limited | 7.72 Billion INR | 38.872% |
| Bal Pharma Limited | 770.19 Million INR | -512.715% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 97.116% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -27.701% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -791.85% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | 48.742% |
| Shilpa Medicare Limited | 3.56 Billion INR | -32.488% |
| Valiant Laboratories Limited | 138.02 Million INR | -3318.919% |
| Ajanta Pharma Limited | 21.06 Billion INR | 77.596% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -4075.123% |
| Granules India Limited | 16.79 Billion INR | 71.909% |
| Medicamen Biotech Limited | 495.49 Million INR | -852.401% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -743.445% |
| Piramal Enterprises Limited | 8.04 Billion INR | 41.329% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 89.907% |
| NATCO Pharma Limited | 25.73 Billion INR | 81.663% |
| Suven Life Sciences Limited | -200.79 Million INR | 2450.185% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 4439.522% |
| Strides Pharma Science Limited | 14.38 Billion INR | 67.201% |
| Indoco Remedies Limited | 8.04 Billion INR | 41.327% |
| Alpa Laboratories Limited | 188.89 Million INR | -2398.266% |
| Lasa Supergenerics Limited | 121.02 Million INR | -3799.116% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -1106.727% |